Investigation announced for Investors in Exscientia plc (NASDAQ: EXAI) over possible Violations of Securities Laws

Exscientia plc is under investigation over potential securities laws violations in connection with certain financial statements.

Investors who purchased shares of Exscientia plc (NASDAQ: EXAI), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on possible claims on behalf of purchasers of the securities of Exscientia plc (NASDAQ: EXAI) concerning whether a series of statements by Exscientia plc regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

United Kingdom based Exscientia plc, an artificial intelligence (AI) driven Pharma-tech company, engages in design and develop differentiated medicines for diseases with high unmet patient needs.

On February 13, 2024, Exscientia plc announced the termination of Andrew Hopkins as the company's Chief Executive Officer and Principal Executive Officer, as well as his removal as an Executive Director of the Board, effective immediately and for cause. This decision by the Board of Directors was made following an investigation that revealed Dr. Hopkins had engaged in inappropriate relationships with two employees, which were deemed inconsistent with the company's standards and values.
Further details emerged as a special committee of the board enlisted outside counsel to investigate the alleged conduct of the executive. The inquiry uncovered, per news reports, that David Nicholson, the board chairman, had prior knowledge of one of Hopkins' relationships and addressed it independently with outside counsel, rather than consulting with the board. Subsequently, after discussions with other board members, Nicholson resigned from his board position.

Shares of Exscientia plc (NASDAQ: EXAI) declined from $7.91 per share on February 12, 2024, to $4.33 per share on April 15, 2024.

Those who purchased shares of Exscientia plc (NASDAQ: EXAI) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.